In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.

References

1. Afeltra J., Dannaoui E., Meis J. F. G. M., Rodriguez-Tudela J. L., Verweij P. E. 2002; In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob Agents Chemother 46:3323–3326 [View Article][PubMed]
   [Google Scholar]
2. Biswas C., Sorrell T. C., Djordjevic J. T., Zuo X., Jolliffe K. A., Chen S. C.-A. 2013; In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. J Antimicrob Chemother 68:2842–2846 [View Article][PubMed]
   [Google Scholar]
3. Cuenca-Estrella M., Alastruey-Izquierdo A., Alcazar-Fuoli L., Bernal-Martinez L., Gomez-Lopez A., Buitrago M. J., Mellado E., Rodriguez-Tudela J. L. 2008; In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother 52:1136–1139 [View Article][PubMed]
   [Google Scholar]
4. Dannaoui E., Lortholary O., Dromer F. 2004; In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother 48:970–978 [View Article][PubMed]
   [Google Scholar]
5. Ferguson L. M., Dreisbach A. W., Csongrádi E., Juncos L. A., Fulop T. 2013; Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban. Am J Med Sci 345:256–258 [View Article][PubMed]
   [Google Scholar]
6. Imbert S., Palous M., Meyer I., Dannaoui E., Mazier D., Datry A., Fekkar A. 2014; In vitro combination of voriconazole and miltefosine against clinically relevant molds. Antimicrob Agents Chemother 58:6996–6998 [View Article][PubMed]
   [Google Scholar]
7. Kesson A. M., Bellemore M. C., O’Mara T. J., Ellis D. H., Sorrell T. C. 2009; Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis 48:1257–1261 [View Article][PubMed]
   [Google Scholar]
8. Lackner M., Fernández-Silva F., Guarro J., Lass-Flörl C. 2014; Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii. J Antimicrob Chemother 69:3027–3032 [View Article][PubMed]
   [Google Scholar]
9. Meletiadis J., Mouton J. W., Meis J. F. G. M., Verweij P. E. 2003; In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 47:106–117 [View Article][PubMed]
   [Google Scholar]
10. Rodríguez M. M., Calvo E., Serena C., Mariné M., Pastor F. J., Guarro J. 2009; Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother 53:2153–2155 [View Article][PubMed]
    [Google Scholar]
11. Sitterlé E., Giraud S., Leto J., Bouchara J. P., Rougeron A., Morio F., Dauphin B., Angebault C., Quesne G. et al. 2013; Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species. Clin Microbiol Infect 20:929–935 [View Article][PubMed]
    [Google Scholar]
12. Tong Z., Widmer F., Sorrell T. C., Guse Z., Jolliffe K. A., Halliday C., Lee O. C., Kong F., Wright L. C., Chen S. C. A. 2007; In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes. Antimicrob Agents Chemother 51:2219–2222 [View Article][PubMed]
    [Google Scholar]
13. Tortorano A. M., Richardson M., Roilides E., van Diepeningen A., Caira M., Munoz P., Johnson E., Meletiadis J., Pana Z.-D. et al. 2014; ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20:Suppl. 327–46 [View Article][PubMed]
    [Google Scholar]
14. Troke P., Aguirrebengoa K., Arteaga C., Ellis D., Heath C. H., Lutsar I., Rovira M., Nguyen Q., Slavin M., Chen S. C.Global Scedosporium Study Group 2008; Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 52:1743–1750 [View Article][PubMed]
    [Google Scholar]
15. Trubiano J. A., Paratz E., Wolf M., Teh B. W., Todaro M., Thursky K. A., Slavin M. A. 2014; Disseminated Scedosporium prolificans infection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics. Mycoses 57:572–576 [View Article][PubMed]
    [Google Scholar]
16. Widmer F., Wright L. C., Obando D., Handke R., Ganendren R., Ellis D. H., Sorrell T. C. 2006; Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis. Antimicrob Agents Chemother 50:414–421 [View Article][PubMed]
    [Google Scholar]
17. Yustes C., Guarro J. 2005; In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp. Antimicrob Agents Chemother 49:3498–3500 [View Article][PubMed]
    [Google Scholar]